UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007358
Receipt number R000006517
Scientific Title Japan Diabetes & Obesity Study (J-DOS) supported by Clinical Study of Network for Endocrine and metabolic Diseases, Policy-Based Medical Service of National Hospital Organization.
Date of disclosure of the study information 2012/02/22
Last modified on 2013/03/21 20:35:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Japan Diabetes & Obesity Study (J-DOS) supported by Clinical Study of Network for Endocrine and metabolic Diseases, Policy-Based Medical Service of National Hospital Organization.

Acronym

Japan Diabetes & Obesity Study (J-DOS)

Scientific Title

Japan Diabetes & Obesity Study (J-DOS) supported by Clinical Study of Network for Endocrine and metabolic Diseases, Policy-Based Medical Service of National Hospital Organization.

Scientific Title:Acronym

Japan Diabetes & Obesity Study (J-DOS)

Region

Japan


Condition

Condition

Diabetes, Obesity

Classification by specialty

Medicine in general Cardiology Endocrinology and Metabolism
Nephrology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Identification of early predictive indicators in lipid profile and inflammatory molecules for preventing cardiovasucular disease.

Basic objectives2

Others

Basic objectives -Others

Establishment of effective treatment programs for the prevention of cardio-renal interaction.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1.Cardio Ankle Vascular Index: CAVI
2.eGFR and CKD stage

Key secondary outcomes

The incidence of cardiovascular disease and chronic kidney disease, and total mortality


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

1)Diet therapy:
i)30kcal/kg of ideal body weight per day for diabetic patients.
ii)25kcal/kg of ideal body weight per day for obese patients.
2)Exercise therapy:
10,000 step walking per day, or exercise of 15-30 minutes at 2 times per day.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1) type 2 diabetes patients.
2) obese patients, Body Mass Index (BMI) is more than 25.

Key exclusion criteria

1) Severe Liver Dysfunction and Liver cirrhosis.
2) Severe Renal Dysfunction.

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Noriko Satoh

Organization

Clinical Research Institute, National Hospital Organization, Kyoto Medical Center

Division name

Division of Diabetes

Zip code


Address

1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto-city

TEL

0756419161

Email



Public contact

Name of contact person

1st name
Middle name
Last name Noriko Satoh

Organization

Clinical Research Institute, National Hospital Organization, Kyoto Medical Center

Division name

Division of Diabetes

Zip code


Address

1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto-city

TEL

0756419161

Homepage URL


Email

nsato@kyotolan.hosp.go.jp


Sponsor or person

Institute

Japan Diabetes & Obesity Study (J-DOS) Network Group.

Institute

Department

Personal name



Funding Source

Organization

Multi-centered Clinical Research, the Policy-Based Medical Service Network, National Hospital Organization

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構 京都医療センター、小倉医療センター、名古屋医療センター、三重病院、長崎川棚医療センター、九州医療センター、徳島病院、金沢医療センター、熊本医療センター、函館病院、長野病院、三重中央医療センター、埼玉病院、宇治徳洲会病院、広島西医療センター、大石内科クリニック


Other administrative information

Date of disclosure of the study information

2012 Year 02 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2010 Year 08 Month 16 Day

Date of IRB


Anticipated trial start date

2010 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 02 Month 22 Day

Last modified on

2013 Year 03 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006517


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name